In mouse xenograft models [39], PDL1-blocking Ab or shRNA knockdown synergized with the hormone to diminish tumor cell growth, claiming that the combination of high-dose androgen with PD1/PDL1 inhibitors may ameliorate cancer immunosurveillance. Here, PDCD1 is linked to cancer.